J.C.T. van Deutekom

4.1k total citations · 1 hit paper
43 papers, 3.3k citations indexed

About

J.C.T. van Deutekom is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, J.C.T. van Deutekom has authored 43 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 13 papers in Genetics and 11 papers in Genetics. Recurrent topics in J.C.T. van Deutekom's work include Muscle Physiology and Disorders (36 papers), Virus-based gene therapy research (12 papers) and RNA Research and Splicing (12 papers). J.C.T. van Deutekom is often cited by papers focused on Muscle Physiology and Disorders (36 papers), Virus-based gene therapy research (12 papers) and RNA Research and Splicing (12 papers). J.C.T. van Deutekom collaborates with scholars based in Netherlands, United Kingdom and United States. J.C.T. van Deutekom's co-authors include Gert‐Jan B. van Ommen, Annemieke Aartsma‐Rus, Johan T. den Dunnen, Ivo F.A.C. Fokkema, Anneke A. M. Janson, Johnny Huard, Ryan Pruchnic, Levent Balkir, Zhuqing Qu and Paul D. Robbins and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Blood.

In The Last Decade

J.C.T. van Deutekom

42 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule

2006 531 citations Annemieke Aartsma‐Rus, J.C.T. van Deutekom et al. Muscle & Nerve profile →

Peers

Countries citing papers authored by J.C.T. van Deutekom

Since Specialization

Citations

This map shows the geographic impact of J.C.T. van Deutekom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C.T. van Deutekom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C.T. van Deutekom more than expected).

Fields of papers citing papers by J.C.T. van Deutekom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.C.T. van Deutekom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C.T. van Deutekom. The network helps show where J.C.T. van Deutekom may publish in the future.

Co-authorship network of co-authors of J.C.T. van Deutekom

This figure shows the co-authorship network connecting the top 25 collaborators of J.C.T. van Deutekom. A scholar is included among the top collaborators of J.C.T. van Deutekom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C.T. van Deutekom. J.C.T. van Deutekom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide 2019 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), (unknown), (unknown), Ruurd C. Verheul, Sieto Bosgra, (unknown), Jukka Puoliväli, (unknown), J.C.T. van Deutekom, Nicole A. Datson	37
2	Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro 2017 ·Nucleic Acid Therapeutics ·(unknown), (unknown), (unknown), (unknown), Huib J. E. Croes, Begoña Aguilera, (unknown), Nicole A. Datson, Susan Mulders, J.C.T. van Deutekom, Bé Wieringa, Derick G. Wansink	20
3	The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain 2017 ·PLoS ONE ·Nicole A. Datson, (unknown), (unknown), (unknown), (unknown), Susan Mulders, Outi Kontkanen, Taneli Heikkinen, Kimmo Lehtimäki, J.C.T. van Deutekom	51
4	Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy 2015 ·PLoS ONE ·(unknown), (unknown), Huib J. E. Croes, (unknown), Walther J. A. A. van den Broek, (unknown), Baziel G.M. van Engelen, J.C.T. van Deutekom, Bé Wieringa, Susan Mulders, Derick G. Wansink	25
5	The Dynamics of Compound, Transcript, and Protein Effects After Treatment With 2OMePS Antisense Oligonucleotides in mdx Mice 2014 ·Molecular Therapy — Nucleic Acids ·Ingrid E.C. Verhaart, (unknown), Jessica A. Sipkens, Sjef J. de Kimpe, Ingrid Kolfschoten, J.C.T. van Deutekom, Lia Liefaard, (unknown), Steve R. Hood, Annemieke Aartsma‐Rus	25
6	Exonic Sequences Provide Better Targets for Antisense Oligonucleotides Than Splice Site Sequences in the Modulation of Duchenne Muscular Dystrophy Splicing 2010 ·Oligonucleotides ·Annemieke Aartsma‐Rus, (unknown), J.C.T. van Deutekom, Gert‐Jan B. van Ommen, Peter A.C. ’t Hoen	33
7	Development of Antisense‐Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy 2009 ·Annals of the New York Academy of Sciences ·Hans Heemskerk, C.L. de Winter, Gert‐Jan B. van Ommen, J.C.T. van Deutekom, Annemieke Aartsma‐Rus	26
8	Generation and Characterization of Transgenic Mice with the Full-length Human DMD Gene 2007 ·Journal of Biological Chemistry ·Peter A.C. ’t Hoen, Emile J. de Meijer, Judith M. Boer, Rolf H. A. M. Vossen, Rolf Turk, R. Maatman, Kay E. Davies, Gert‐Jan B. van Ommen, J.C.T. van Deutekom, Johan T. den Dunnen	64
9	Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule breakdown → 2006 ·Muscle & Nerve ·Annemieke Aartsma‐Rus, J.C.T. van Deutekom, Ivo F.A.C. Fokkema, Gert‐Jan B. van Ommen, Johan T. den Dunnen	531
10	Exploring the Frontiers of Therapeutic Exon Skipping for Duchenne Muscular Dystrophy by Double Targeting within One or Multiple Exons 2006 ·Molecular Therapy ·Annemieke Aartsma‐Rus, (unknown), (unknown), Johan T. den Dunnen, Gert‐Jan B. van Ommen, J.C.T. van Deutekom	65
11	Gene Therapy: The ‘pro-sense’ approach to Duchenne muscular dystrophy 2005 ·European Journal of Human Genetics ·J.C.T. van Deutekom	11
12	Functional Analysis of 114 Exon-Internal AONs for Targeted DMD Exon Skipping: Indication for Steric Hindrance of SR Protein Binding Sites 2005 ·Oligonucleotides ·Annemieke Aartsma‐Rus, C.L. de Winter, Anneke A. M. Janson, (unknown), Gert‐Jan B. van Ommen, Johan T. den Dunnen, J.C.T. van Deutekom	91
13	Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense 2004 ·The American Journal of Human Genetics ·Annemieke Aartsma‐Rus, Anneke A. M. Janson, (unknown), (unknown), Gert‐Jan B. van Ommen, Johan T. den Dunnen, J.C.T. van Deutekom	152
14	Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense Oligonucleotides 2004 ·Molecular Therapy ·(unknown), Annemieke Aartsma‐Rus, Emile J. de Meijer, (unknown), Anneke A. M. Janson, Rolf H. A. M. Vossen, Gert‐Jan B. van Ommen, Johan T. den Dunnen, J.C.T. van Deutekom	95
15	Advances in Duchenne muscular dystrophy gene therapy 2003 ·Nature Reviews Genetics ·J.C.T. van Deutekom, Gert‐Jan B. van Ommen	171
16	Identification of a novel β-tubulin subfamily with one member (TUBB4Q) located near the telomere of chromosome region 4q35 2000 ·Cytogenetic and Genome Research ·Michel van Geel, J.C.T. van Deutekom, (unknown), Richard J.L.F. Lemmers, (unknown), (unknown), George W. Padberg, Jane Hewitt, Pieter J. de Jong, Rune R. Frants	27
17	Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle 1999 ·The Journal of Gene Medicine ·J.C.T. van Deutekom, Baohong Cao, Ryan Pruchnic, Thomas J. Wickham, Imre Kovesdi, Johnny Huard	24
18	Muscle maturation: implications for gene therapy 1998 ·Molecular Medicine Today ·J.C.T. van Deutekom, Eric P. Hoffman, Johnny Huard	34
19	Implications of maturation for viral gene delivery to skeletal muscle 1998 ·Neuromuscular Disorders ·J.C.T. van Deutekom, (unknown), (unknown), Thomas Oligino, David Krisky, Peggy Marconi, Joseph C. Glorioso, Johnny Huard	50
20	Pulsed-Field Gel Electrophoresis of the D4F104S1 Locus Reveals the Size and the Parental Origin of the Facioscapulohumeral Muscular Dystrophy (FSHD)-Associated Deletions 1994 ·Genomics ·Cisca Wijmenga, J.C.T. van Deutekom, Jane Hewitt, George W. Padberg, Gert‐Jan B. van Ommen, Marten H. Hofker, Rune R. Frants	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact